secwatch.observer — SEC 8-K summary
======================================

Issuer:     Applied Therapeutics, Inc. (—)
CIK:        0001697532
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001193125-25-316607
Event type: m_and_a
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied Therapeutics to be acquired by Cycle Group for $0.088/share plus CVRs worth up to $0.40
--------------------------------------------------------------------------------

- Offer price: $0.088 per share cash plus one non-tradeable CVR with up to $0.40 per share in milestone payments.
- Milestones include FDA approval for galactosemia ($0.10), CMT-SORD ($0.10), and net sales >= $200M ($0.20).
- Parent provides up to $8.5M unsecured promissory note at 24% interest to fund working capital pending close.
- Board unanimously approved; transaction subject to tender of majority of shares and other customary conditions.
- Termination fee of $648,000 plus 4.5% of outstanding note principal payable by Applied in certain circumstances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1697532/000119312525316607/0001193125-25-316607-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1697532/000119312525316607/d41524d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-316607

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer